Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-07-02
2000-11-07
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544276, 544265, 544277, 544118, 544261, 544262, 544266, C07D47300, C07D41300
Patent
active
061437433
ABSTRACT:
Corticotropin releasing factor (CRF) antagonists of formula (I): ##STR1## and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress in mammals.
REFERENCES:
patent: 4797399 (1989-01-01), Ueda et al.
patent: 5015473 (1991-05-01), Chen
patent: 5075311 (1991-12-01), Hubsch et al.
patent: 5102880 (1992-04-01), Chakravarty et al.
patent: 5128327 (1992-07-01), Chakravarty et al.
patent: 5145959 (1992-09-01), Hubsch et al.
patent: 5157026 (1992-10-01), Chakravarty et al.
patent: 5171353 (1992-12-01), Fischer et al.
patent: 5176991 (1993-01-01), Jones et al.
patent: 5178997 (1993-01-01), Maskasky
patent: 5187159 (1993-02-01), Greenlee et al.
patent: 5250531 (1993-10-01), Cooper
patent: 5260322 (1993-11-01), Nakasima et al.
patent: 5330989 (1994-07-01), Soll et al.
patent: 5332814 (1994-07-01), Moser
patent: 5332820 (1994-07-01), Duncia
patent: 5338740 (1994-08-01), Carpino et al.
patent: 5338756 (1994-08-01), Fortin et al.
patent: 5374638 (1994-12-01), Dhanoa et al.
patent: 5376665 (1994-12-01), Miyata et al.
patent: 5376666 (1994-12-01), Duncia
patent: 5385925 (1995-01-01), Narr et al.
patent: 5389634 (1995-02-01), Fortin et al.
patent: 5389641 (1995-02-01), Naka et al.
patent: 5395840 (1995-03-01), Muler et al.
patent: 5424432 (1995-06-01), Fredenburgh et al.
patent: 5434150 (1995-07-01), Austel et al.
patent: 5444068 (1995-08-01), Heitsch et al.
patent: 5446159 (1995-08-01), Stucky et al.
patent: 5446160 (1995-08-01), Stucky et al.
patent: 5459147 (1995-10-01), Hauel et al.
patent: 5470867 (1995-11-01), Fortin et al.
patent: 5498715 (1996-03-01), Kuo et al.
patent: 5514682 (1996-05-01), Street
patent: 5541324 (1996-07-01), TenBrink et al.
patent: 5565437 (1996-10-01), Marquez et al.
patent: 5580981 (1996-12-01), Carpino
patent: 5587393 (1996-12-01), Narr et al.
patent: 5587470 (1996-12-01), Cook et al.
patent: 5597826 (1997-01-01), Howard et al.
patent: 5635525 (1997-06-01), Heitsch et al.
patent: 5684029 (1997-11-01), Narr et al.
Mataka et al, Reduction of 4,7-Diphenyl-1,2,5-thia(oxa)diazolo[3,4-3]pyridines Affording 2,5-Diphenyl-3,4-diaminoopyridines and Ring Closure of the Diamines to Fluorescent Azaheterocycles, Jrnl of Heterocyclic Chem., 19/6,1481-1488, (1982).
Kalme et al, Nucleophilic Substitution in. . . , Khim Geterotsikl Soedin, 12, 1646-1650, (1992).
Kiyama et al., Synthesis and Evaluation of Novel Nonpeptide Angiotensin III Receptor Antagonists. . . , Chem. Pharm Bull., 43/3, 450-460, (1995) PCT International Search Report PCT/US/98/13913.
Arvanitis Argyrios Georgious
Bakthavatchalam Rajagopal
Beck James Peter
Wilde Richard Gerald
Browder Monte R.
DuPont Pharmaceuticals Company
Liu Hong
O'Brien Maureen P.
Rubin Kenneth B.
LandOfFree
Imidazopyrimidines and imidazopyridines for the treatment of neu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyrimidines and imidazopyridines for the treatment of neu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyrimidines and imidazopyridines for the treatment of neu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1641306